+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Somatostatin"

Somatostatin Analogs - Global Strategic Business Report - Product Thumbnail Image

Somatostatin Analogs - Global Strategic Business Report

  • Report
  • March 2026
  • 280 Pages
  • Global
From
Neuroendocrine Tumor Treatment Market Report 2026 - Product Thumbnail Image

Neuroendocrine Tumor Treatment Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Zollinger-Ellison Syndrome Treatment Market Report 2026 - Product Thumbnail Image

Zollinger-Ellison Syndrome Treatment Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Acromegaly Market Report 2026 - Product Thumbnail Image

Acromegaly Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Somatostatin Analogs Market Report 2026 - Product Thumbnail Image

Somatostatin Analogs Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Endocrinology Drugs Market Report 2026 - Product Thumbnail Image

Endocrinology Drugs Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Octreotide Market Report 2026 - Product Thumbnail Image

Octreotide Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Radioligand Therapy Market Report 2026 - Product Thumbnail Image

Radioligand Therapy Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Neuroendocrine Carcinoma Market Report 2026 - Product Thumbnail Image

Neuroendocrine Carcinoma Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
From
Neuroendocrine Tumors - Pipeline Insight, 2025 - Product Thumbnail Image

Neuroendocrine Tumors - Pipeline Insight, 2025

  • Clinical Trials
  • July 2025
  • 280 Pages
  • Global
From
From
Advanced Merkel Cell Carcinoma - Pipeline Insight, 2025 - Product Thumbnail Image

Advanced Merkel Cell Carcinoma - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 80 Pages
  • Global
From
Acromegaly- Pipeline Insight, 2025 - Product Thumbnail Image

Acromegaly- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Carcinoid Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Carcinoid Syndrome - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Pediatric Growth Hormone Deficiency - Pipeline Insight, 2025 - Product Thumbnail Image

Pediatric Growth Hormone Deficiency - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
From
From
Loading Indicator

Somatostatin is a peptide hormone that is used in the treatment of various types of cancer. It is used to inhibit the release of growth hormones, which can help reduce the size of tumors. It is also used to reduce the side effects of chemotherapy and radiation therapy. Somatostatin is available in both injectable and oral forms. It is often used in combination with other drugs to treat cancer. Somatostatin is used to treat a variety of cancers, including pancreatic, prostate, and neuroendocrine tumors. It is also used to treat acromegaly, a condition caused by excessive growth hormone production. Somatostatin is also used to treat Cushing's syndrome, a condition caused by excessive cortisol production. Some companies that produce somatostatin include Novartis, Merck, and Pfizer. Other companies that produce somatostatin-based drugs include Ipsen, Teva, and Sandoz. Show Less Read more